img

Global Flunixin Meglumine Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Flunixin Meglumine Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals
Flunixin Meglumine Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Flunixin Meglumine Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Animal muscle pain and Animal febrile disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Flunixin Meglumine Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Flunixin Meglumine Injection key manufacturers include Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd. and Baimukang Animal Pharmaceutical Co., Ltd., etc. Norbrook, Zoteis, Merck Animal Health are top 3 players and held % sales share in total in 2022.
Flunixin Meglumine Injection can be divided into 10ml/Dose and 20ml/ Dose, etc. 10ml/Dose is the mainstream product in the market, accounting for % sales share globally in 2022.
Flunixin Meglumine Injection is widely used in various fields, such as Animal muscle pain, Animal febrile disease and Others,, etc. Animal muscle pain provides greatest supports to the Flunixin Meglumine Injection industry development. In 2022, global % sales of Flunixin Meglumine Injection went into Animal muscle pain filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Flunixin Meglumine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Segment by Type
10ml/Dose
20ml/ Dose

Segment by Application


Animal muscle pain
Animal febrile disease
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Flunixin Meglumine Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Flunixin Meglumine Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Flunixin Meglumine Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Flunixin Meglumine Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Flunixin Meglumine Injection introduction, etc. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Flunixin Meglumine Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Flunixin Meglumine Injection Market Overview
1.1 Flunixin Meglumine Injection Product Overview
1.2 Flunixin Meglumine Injection Market Segment by Type
1.2.1 10ml/Dose
1.2.2 20ml/ Dose
1.3 Global Flunixin Meglumine Injection Market Size by Type
1.3.1 Global Flunixin Meglumine Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Flunixin Meglumine Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Flunixin Meglumine Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Flunixin Meglumine Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Flunixin Meglumine Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Flunixin Meglumine Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Flunixin Meglumine Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Flunixin Meglumine Injection Sales Breakdown by Type (2024-2024)
2 Global Flunixin Meglumine Injection Market Competition by Company
2.1 Global Top Players by Flunixin Meglumine Injection Sales (2024-2024)
2.2 Global Top Players by Flunixin Meglumine Injection Revenue (2024-2024)
2.3 Global Top Players by Flunixin Meglumine Injection Price (2024-2024)
2.4 Global Top Manufacturers Flunixin Meglumine Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Flunixin Meglumine Injection Market Competitive Situation and Trends
2.5.1 Flunixin Meglumine Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Flunixin Meglumine Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flunixin Meglumine Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Flunixin Meglumine Injection Market
2.8 Key Manufacturers Flunixin Meglumine Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Flunixin Meglumine Injection Status and Outlook by Region
3.1 Global Flunixin Meglumine Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Flunixin Meglumine Injection Historic Market Size by Region
3.2.1 Global Flunixin Meglumine Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Flunixin Meglumine Injection Sales in Value by Region (2024-2024)
3.2.3 Global Flunixin Meglumine Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Flunixin Meglumine Injection Forecasted Market Size by Region
3.3.1 Global Flunixin Meglumine Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Flunixin Meglumine Injection Sales in Value by Region (2024-2034)
3.3.3 Global Flunixin Meglumine Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Flunixin Meglumine Injection by Application
4.1 Flunixin Meglumine Injection Market Segment by Application
4.1.1 Animal muscle pain
4.1.2 Animal febrile disease
4.1.3 Others
4.2 Global Flunixin Meglumine Injection Market Size by Application
4.2.1 Global Flunixin Meglumine Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Flunixin Meglumine Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Flunixin Meglumine Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Flunixin Meglumine Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Flunixin Meglumine Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Flunixin Meglumine Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Flunixin Meglumine Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Flunixin Meglumine Injection Sales Breakdown by Application (2024-2024)
5 North America Flunixin Meglumine Injection by Country
5.1 North America Flunixin Meglumine Injection Historic Market Size by Country
5.1.1 North America Flunixin Meglumine Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Flunixin Meglumine Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Flunixin Meglumine Injection Sales in Value by Country (2024-2024)
5.2 North America Flunixin Meglumine Injection Forecasted Market Size by Country
5.2.1 North America Flunixin Meglumine Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Flunixin Meglumine Injection Sales in Value by Country (2024-2034)
6 Europe Flunixin Meglumine Injection by Country
6.1 Europe Flunixin Meglumine Injection Historic Market Size by Country
6.1.1 Europe Flunixin Meglumine Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Flunixin Meglumine Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Flunixin Meglumine Injection Sales in Value by Country (2024-2024)
6.2 Europe Flunixin Meglumine Injection Forecasted Market Size by Country
6.2.1 Europe Flunixin Meglumine Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Flunixin Meglumine Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Flunixin Meglumine Injection by Region
7.1 Asia-Pacific Flunixin Meglumine Injection Historic Market Size by Region
7.1.1 Asia-Pacific Flunixin Meglumine Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Flunixin Meglumine Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Flunixin Meglumine Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Flunixin Meglumine Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Flunixin Meglumine Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Flunixin Meglumine Injection Sales in Value by Region (2024-2034)
8 Latin America Flunixin Meglumine Injection by Country
8.1 Latin America Flunixin Meglumine Injection Historic Market Size by Country
8.1.1 Latin America Flunixin Meglumine Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Flunixin Meglumine Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Flunixin Meglumine Injection Sales in Value by Country (2024-2024)
8.2 Latin America Flunixin Meglumine Injection Forecasted Market Size by Country
8.2.1 Latin America Flunixin Meglumine Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Flunixin Meglumine Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Flunixin Meglumine Injection by Country
9.1 Middle East and Africa Flunixin Meglumine Injection Historic Market Size by Country
9.1.1 Middle East and Africa Flunixin Meglumine Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Flunixin Meglumine Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Flunixin Meglumine Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Flunixin Meglumine Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Flunixin Meglumine Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Flunixin Meglumine Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Norbrook
10.1.1 Norbrook Company Information
10.1.2 Norbrook Introduction and Business Overview
10.1.3 Norbrook Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Norbrook Flunixin Meglumine Injection Products Offered
10.1.5 Norbrook Recent Development
10.2 Zoteis
10.2.1 Zoteis Company Information
10.2.2 Zoteis Introduction and Business Overview
10.2.3 Zoteis Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Zoteis Flunixin Meglumine Injection Products Offered
10.2.5 Zoteis Recent Development
10.3 Merck Animal Health
10.3.1 Merck Animal Health Company Information
10.3.2 Merck Animal Health Introduction and Business Overview
10.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Merck Animal Health Flunixin Meglumine Injection Products Offered
10.3.5 Merck Animal Health Recent Development
10.4 Virbac Animal Health India Private Limited
10.4.1 Virbac Animal Health India Private Limited Company Information
10.4.2 Virbac Animal Health India Private Limited Introduction and Business Overview
10.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Products Offered
10.4.5 Virbac Animal Health India Private Limited Recent Development
10.5 MSD Animal Health
10.5.1 MSD Animal Health Company Information
10.5.2 MSD Animal Health Introduction and Business Overview
10.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 MSD Animal Health Flunixin Meglumine Injection Products Offered
10.5.5 MSD Animal Health Recent Development
10.6 Bengal Remedies Limited
10.6.1 Bengal Remedies Limited Company Information
10.6.2 Bengal Remedies Limited Introduction and Business Overview
10.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Products Offered
10.6.5 Bengal Remedies Limited Recent Development
10.7 Wuhan Huisheng Biological Technology Co., Ltd.
10.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
10.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Introduction and Business Overview
10.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Products Offered
10.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Development
10.8 Qilu Animal Health Products Co., Ltd.
10.8.1 Qilu Animal Health Products Co., Ltd. Company Information
10.8.2 Qilu Animal Health Products Co., Ltd. Introduction and Business Overview
10.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Products Offered
10.8.5 Qilu Animal Health Products Co., Ltd. Recent Development
10.9 Baimukang Animal Pharmaceutical Co., Ltd.
10.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information
10.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Introduction and Business Overview
10.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Development
10.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
10.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
10.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Introduction and Business Overview
10.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Products Offered
10.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Development
10.11 Hebei New Century Pharmaceutical Co., Ltd.
10.11.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information
10.11.2 Hebei New Century Pharmaceutical Co., Ltd. Introduction and Business Overview
10.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.11.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Development
10.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
10.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
10.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Introduction and Business Overview
10.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Development
10.13 Shandong Lukang Pharmaceutical Co., Ltd.
10.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
10.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Introduction and Business Overview
10.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Flunixin Meglumine Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Flunixin Meglumine Injection Industrial Chain Analysis
11.4 Flunixin Meglumine Injection Market Dynamics
11.4.1 Flunixin Meglumine Injection Industry Trends
11.4.2 Flunixin Meglumine Injection Market Drivers
11.4.3 Flunixin Meglumine Injection Market Challenges
11.4.4 Flunixin Meglumine Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Flunixin Meglumine Injection Distributors
12.3 Flunixin Meglumine Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 10ml/Dose
Table 2. Major Company of 20ml/ Dose
Table 3. Global Flunixin Meglumine Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Flunixin Meglumine Injection Sales by Type (2024-2024) & (K Doses)
Table 5. Global Flunixin Meglumine Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Flunixin Meglumine Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global Flunixin Meglumine Injection Market Share in Value by Type (2024-2024)
Table 8. Global Flunixin Meglumine Injection Price by Type (2024-2024) & (US$/Dose)
Table 9. Global Flunixin Meglumine Injection Sales by Type (2024-2034) & (K Doses)
Table 10. Global Flunixin Meglumine Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Flunixin Meglumine Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Flunixin Meglumine Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Flunixin Meglumine Injection Price by Type (2024-2034) & (US$/Dose)
Table 14. North America Flunixin Meglumine Injection Sales by Type (2024-2024) & (K Doses)
Table 15. North America Flunixin Meglumine Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Flunixin Meglumine Injection Sales (K Doses) by Type (2024-2024)
Table 17. Europe Flunixin Meglumine Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Flunixin Meglumine Injection Sales (K Doses) by Type (2024-2024)
Table 19. Asia-Pacific Flunixin Meglumine Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Flunixin Meglumine Injection Sales (K Doses) by Type (2024-2024)
Table 21. Latin America Flunixin Meglumine Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Flunixin Meglumine Injection Sales (K Doses) by Type (2024-2024)
Table 23. Middle East and Africa Flunixin Meglumine Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Flunixin Meglumine Injection Sales by Company (2024-2024) & (K Doses)
Table 25. Global Flunixin Meglumine Injection Sales Share by Company (2024-2024)
Table 26. Global Flunixin Meglumine Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Flunixin Meglumine Injection Revenue Share by Company (2024-2024)
Table 28. Global Market Flunixin Meglumine Injection Price by Company (2024-2024) & (US$/Dose)
Table 29. Global Flunixin Meglumine Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Flunixin Meglumine Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flunixin Meglumine Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Flunixin Meglumine Injection Market
Table 33. Key Manufacturers Flunixin Meglumine Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Flunixin Meglumine Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Flunixin Meglumine Injection Sales by Region (2024-2024) & (K Doses)
Table 37. Global Flunixin Meglumine Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Flunixin Meglumine Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Flunixin Meglumine Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 41. Global Flunixin Meglumine Injection Sales by Region (2024-2034) & (K Doses)
Table 42. Global Flunixin Meglumine Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Flunixin Meglumine Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Flunixin Meglumine Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2034)
Table 46. Global Flunixin Meglumine Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Flunixin Meglumine Injection Sales by Application (2024-2024) & (K Doses)
Table 48. Global Flunixin Meglumine Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Flunixin Meglumine Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Flunixin Meglumine Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global Flunixin Meglumine Injection Price by Application (2024-2024) & (US$/Dose)
Table 52. Global Flunixin Meglumine Injection Sales by Application (2024-2034) & (K Doses)
Table 53. Global Flunixin Meglumine Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Flunixin Meglumine Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Flunixin Meglumine Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Flunixin Meglumine Injection Price by Application (2024-2034) & (US$/Dose)
Table 57. North America Flunixin Meglumine Injection Sales by Application (2024-2024) (K Doses)
Table 58. North America Flunixin Meglumine Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Flunixin Meglumine Injection Sales by Application (2024-2024) (K Doses)
Table 60. Europe Flunixin Meglumine Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Flunixin Meglumine Injection Sales by Application (2024-2024) (K Doses)
Table 62. Asia-Pacific Flunixin Meglumine Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Flunixin Meglumine Injection Sales by Application (2024-2024) (K Doses)
Table 64. Latin America Flunixin Meglumine Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Flunixin Meglumine Injection Sales by Application (2024-2024) (K Doses)
Table 66. Middle East and Africa Flunixin Meglumine Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Flunixin Meglumine Injection Sales by Country (2024-2024) & (K Doses)
Table 68. North America Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Flunixin Meglumine Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America Flunixin Meglumine Injection Sales by Country (2024-2034) & (K Doses)
Table 72. North America Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Flunixin Meglumine Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Flunixin Meglumine Injection Sales by Country (2024-2024) & (K Doses)
Table 76. Europe Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Flunixin Meglumine Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Flunixin Meglumine Injection Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Flunixin Meglumine Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Flunixin Meglumine Injection Sales by Region (2024-2024) & (K Doses)
Table 84. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Flunixin Meglumine Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Flunixin Meglumine Injection Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Flunixin Meglumine Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Flunixin Meglumine Injection Sales by Country (2024-2024) & (K Doses)
Table 92. Latin America Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Flunixin Meglumine Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Flunixin Meglumine Injection Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Flunixin Meglumine Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2024-2024) & (K Doses)
Table 100. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Norbrook Company Information
Table 108. Norbrook Introduction and Business Overview
Table 109. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 110. Norbrook Flunixin Meglumine Injection Product
Table 111. Norbrook Recent Development
Table 112. Zoteis Company Information
Table 113. Zoteis Introduction and Business Overview
Table 114. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 115. Zoteis Flunixin Meglumine Injection Product
Table 116. Zoteis Recent Development
Table 117. Merck Animal Health Company Information
Table 118. Merck Animal Health Introduction and Business Overview
Table 119. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 120. Merck Animal Health Flunixin Meglumine Injection Product
Table 121. Merck Animal Health Recent Development
Table 122. Virbac Animal Health India Private Limited Company Information
Table 123. Virbac Animal Health India Private Limited Introduction and Business Overview
Table 124. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 125. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product
Table 126. Virbac Animal Health India Private Limited Recent Development
Table 127. MSD Animal Health Company Information
Table 128. MSD Animal Health Introduction and Business Overview
Table 129. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 130. MSD Animal Health Flunixin Meglumine Injection Product
Table 131. MSD Animal Health Recent Development
Table 132. Bengal Remedies Limited Company Information
Table 133. Bengal Remedies Limited Introduction and Business Overview
Table 134. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 135. Bengal Remedies Limited Flunixin Meglumine Injection Product
Table 136. Bengal Remedies Limited Recent Development
Table 137. Wuhan Huisheng Biological Technology Co., Ltd. Company Information
Table 138. Wuhan Huisheng Biological Technology Co., Ltd. Introduction and Business Overview
Table 139. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 140. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product
Table 141. Wuhan Huisheng Biological Technology Co., Ltd. Recent Development
Table 142. Qilu Animal Health Products Co., Ltd. Company Information
Table 143. Qilu Animal Health Products Co., Ltd. Introduction and Business Overview
Table 144. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 145. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product
Table 146. Qilu Animal Health Products Co., Ltd. Recent Development
Table 147. Baimukang Animal Pharmaceutical Co., Ltd. Company Information
Table 148. Baimukang Animal Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 149. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 150. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 151. Baimukang Animal Pharmaceutical Co., Ltd. Recent Development
Table 152. Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
Table 153. Shandong Zhongmu Veterinary Medicine Co., Ltd. Introduction and Business Overview
Table 154. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 155. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product
Table 156. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Development
Table 157. Hebei New Century Pharmaceutical Co., Ltd. Company Information
Table 158. Hebei New Century Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 159. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 160. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 161. Hebei New Century Pharmaceutical Co., Ltd. Recent Development
Table 162. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
Table 163. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 164. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 165. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 166. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Development
Table 167. Shandong Lukang Pharmaceutical Co., Ltd. Company Information
Table 168. Shandong Lukang Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 169. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 170. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 171. Shandong Lukang Pharmaceutical Co., Ltd. Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Flunixin Meglumine Injection Market Trends
Table 175. Flunixin Meglumine Injection Market Drivers
Table 176. Flunixin Meglumine Injection Market Challenges
Table 177. Flunixin Meglumine Injection Market Restraints
Table 178. Flunixin Meglumine Injection Distributors List
Table 179. Flunixin Meglumine Injection Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Flunixin Meglumine Injection Product Picture
Figure 2. Global Flunixin Meglumine Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Flunixin Meglumine Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Flunixin Meglumine Injection Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of 10ml/Dose
Figure 6. Global 10ml/Dose Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of 20ml/ Dose
Figure 8. Global 20ml/ Dose Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Global Flunixin Meglumine Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Flunixin Meglumine Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Flunixin Meglumine Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Flunixin Meglumine Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Flunixin Meglumine Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Flunixin Meglumine Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Flunixin Meglumine Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Flunixin Meglumine Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Flunixin Meglumine Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Flunixin Meglumine Injection Revenue in 2022
Figure 23. Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Animal muscle pain
Figure 25. Global Animal muscle pain Sales YoY Growth (2024-2034) & (K Doses)
Figure 26. Product Picture of Animal febrile disease
Figure 27. Global Animal febrile disease Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Global Flunixin Meglumine Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Flunixin Meglumine Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Flunixin Meglumine Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Flunixin Meglumine Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Flunixin Meglumine Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Flunixin Meglumine Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Flunixin Meglumine Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Flunixin Meglumine Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Flunixin Meglumine Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Flunixin Meglumine Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Flunixin Meglumine Injection Manufacturing Cost Structure
Figure 43. Flunixin Meglumine Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed